Skip to main content

Table 2 Pathway enrichment analysis of genes selected by the G-4, T-4, and TI-4 models when predicting OS (no pathways were significantly enriched for EFS)

From: Predicting survival times for neuroblastoma patients using RNA-seq expression profiles

Outcome

Pathway

Count

Size

P-value

BH

OS

Pathways in cancer

26

393

<0.001

0.010

OS

ErbB signaling pathway

11

87

<0.001

0.012

  1. The columns include KEGG pathway name, the number of genes in the gene set that are in the pathway, the total number of genes annotated for the pathway, the p-value from a modified fisher’s exact test, and the Benjamini-Hochberg corrected p-value
Back to article page

Biology Direct

ISSN: 1745-6150

Contact us